ENTRY       D11360                      Drug
NAME        Tirzepatide (JAN/USAN);
            Mounjaro (TN)
PRODUCT     MOUNJARO (Eli Lilly and Company)
FORMULA     C225H348N48O68
EXACT_MASS  4810.5249
MOL_WEIGHT  4813.4514
SEQUENCE    YXEGTFTSDY SIXLDKIAQK AFVQWLIAGG PSSGAPPPS
  TYPE      Peptide
CLASS       Antidiabetic agent
             DG02044  Hypoglycemic agent
              DG01493  GLP-1 receptor agonist
REMARK      Therapeutic category: 2499
            ATC code: A10BX16
            Product: D11360<JP/US>
EFFICACY    Antidiabetic, Gastric inhibitory polypeptide receptor agonist, Glucagon-like peptide 1 (GLP-1) receptor agonist
  DISEASE   Type 2 diabetes mellitus [DS:H00409]
COMMENT     Treatment of type 2 diabetes
TARGET      GIPR [HSA:2696] [KO:K04580]
            GLP1R [HSA:2740] [KO:K04581]
  PATHWAY   hsa04024(2696+2740)  cAMP signaling pathway
            hsa04080(2696+2740)  Neuroactive ligand-receptor interaction
            hsa04911(2740)  Insulin secretion
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             A ALIMENTARY TRACT AND METABOLISM
              A10 DRUGS USED IN DIABETES
               A10B BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
                A10BX Other blood glucose lowering drugs, excl. insulins
                 A10BX16 Tirzepatide
                  D11360  Tirzepatide (JAN/USAN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Blood Glucose Regulators
              Antidiabetic Agents
               Glucose Control Agents, Other
                Tirzepatide
                 D11360  Tirzepatide (JAN/USAN)
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              24  Hormones
               249  Miscellaneous
                2499  Others
                 D11360  Tirzepatide (JAN/USAN)
            Drug groups [BR:br08330]
             Antidiabetic agent
              DG02044  Hypoglycemic agent
               DG01493  GLP-1 receptor agonist
                D11360  Tirzepatide
            Drug classes [BR:br08332]
             Antidiabetic agent
              DG01493  GLP-1 receptor agonist
               D11360  Tirzepatide
              DG02044  Hypoglycemic agent
               D11360  Tirzepatide
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Secretin receptor family
               Glucagon
                GLP1R
                 D11360  Tirzepatide (JAN/USAN) &lt;JP/US&gt;
               Gastric inhibitory polypeptide
                GIPR
                 D11360  Tirzepatide (JAN/USAN) &lt;JP/US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D11360
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D11360
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D11360
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D11360
DBLINKS     CAS: 2023788-19-2
            PubChem: 384585338
            ChEBI: 194186
///
